🇺🇸 FDA
Pipeline program

uCD7 CART

IIT2025073

Phase 1 mab active

Quick answer

uCD7 CART for Acute Myeloid Leukemia (AML) is a Phase 1 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Acute Myeloid Leukemia (AML)
Phase
Phase 1
Modality
mab
Status
active

Clinical trials